Performance-based Reinforcement to Enhance Cognitive Remediation Therapy
NCT ID: NCT01633138
Last Updated: 2020-03-09
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
40 participants
INTERVENTIONAL
2012-09-30
2014-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Targeting Self-regulatory Deficits Through Cognitive Remediation Intervention
NCT03373240
Computer Based Training in Cognitive Behavioral Therapy Web-based
NCT01442597
Cognitive Remediation and Work Therapy in the Initial Phase of Substance Abuse Treatment
NCT01410110
Cognitive Remediation in Early Substance Abuse Treatment
NCT00334217
Computer-Based Training in Cognitive Behavior Therapy
NCT00350610
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
CRT-S
Cognitive Remediation Therapy - Standard
Cognitive Remediation Therapy - Standard
Computerized cognitive remediation therapy provided three times per week for four weeks
CRT-CM
Cognitive Remediation Therapy plus Contingency Management
Cognitive Remediation Therapy plus Contingency Management
Standard cognitive remediation therapy plus monetary incentives based on performance provided three times per week for four weeks.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Cognitive Remediation Therapy - Standard
Computerized cognitive remediation therapy provided three times per week for four weeks
Cognitive Remediation Therapy plus Contingency Management
Standard cognitive remediation therapy plus monetary incentives based on performance provided three times per week for four weeks.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Primary Alcohol and/or Cocaine Abuse/Dependence Diagnosis
* Abstinence from all drugs/alcohol for 30 days
* Mild cognitive impairment
* Sufficiently stable and plan to commit to 4 weeks of outpatient treatment
* Fluent in English and 6th grade reading ability
Exclusion Criteria
* Untreated bipolar or psychotic disorder
* Have current legal case pending such that incarceration during 4-week study is likely
18 Years
60 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
National Institute on Drug Abuse (NIDA)
NIH
Yale University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Brian D Kiluk, PhD
Role: PRINCIPAL_INVESTIGATOR
Yale University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Substance Abuse Treatment Unit
New Haven, Connecticut, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
1205010253
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.